News | Contrast Media | February 28, 2018

Guerbet Presents Contrast&Care Injection Management Solution at ECR 2018

European conference marks global commercial launch of Contrast&Care to gather and share information on contrast products and procedures

Guerbet Presents Contrast&Care Injection Management Solution at ECR 2018

February 28, 2018 — Guerbet will present its new Contrast&Care application, as well as other contrast media offerings for computed tomography (CT), the cath lab and magnetic resonance imaging (MRI), at the the 2018 European Congress of Radiology (ECR), Feb. 28-March 4 in Vienna, Austria.

Contrast&Care is a class I /CE medical device designed to be used by healthcare professionals only. It is a contrast media injection management solution that enables imaging centers to collect, archive, examine and share injection data, including data on contrast products, adverse events, injector activity, information on estimated glomerular filtration rate (eGFR) and other risk factors before an exam. The solution enables all the information on injections during medical imaging examinations (contrast media, protocols, patient data, etc.) to be combined, and interfaces with the information systems used in radiology such as the radiology information system (RIS) and picture archiving and communication system (PACS) .

With this new solution, available in seven languages, Guerbet said it now features product offerings across the entire value chain. Contrast&Care complements Guerbet's digital services offering in synergy with Dose&Care, the operational solution for tracking patient exposure to ionizing rays. Contrast&Care and Dose&Care will be demonstrated at Guerbet's booth throughout the event.

For more information:


Related Content

The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio
News | Contrast Media Injectors | June 17, 2020
June 17, 2020 — Technavio has been monitoring the ...
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease

Getty Images

News | Contrast Media | June 01, 2020
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for...
Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp

Samples were taken along rivers around Tokyo. Measurements of rare earth element quantities indicate a clearly elevated amount of gadolinium compared to that in natural shale. Graphics courtesy of Tokyo Metropolitan University

News | Magnetic Resonance Imaging (MRI) | May 26, 2020
May 26, 2020 — Researchers from Tokyo Metropolitan...
TeraRecon will accelerate innovation in its advanced visualization and AI platforms for image-related decision support to clinical specialists

TeraRecon's End-to-End AI Ecosystem

News | Artificial Intelligence | March 04, 2020
March 4, 2020 — SymphonyAI Group, an operating group of lea
Feature | Coronavirus (COVID-19) | March 03, 2020 | Dave Fornell, Editor
March 3, 2020 — Two sizable European medical conferences in cardiology and radiology were canceled today as fears con
Carestream’s state-of-the-art OnSight 3D Extremity System
News | Computed Tomography (CT) | February 25, 2020
February 25, 2020 — Carestream’s state-of-the-art...
Altamont’s zero-footprint solution, CaptureWare, allows Mach7’s Enterprise Imaging Platform (EIP) to ingest more DICOM and/or non-DICOM data from various sources in a facility
News | PACS | February 20, 2020
February 20, 2020 — Mach7 announced its partnership with Altamont